SW
USNA icon

SkyOak Wealth’s Usana Health Sciences USNA Stock Holding History

SkyOak Wealth’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,268
Closed -$227K – 267
2022
Q4 		$227K Buy
+4,268
New +$231K 0.08% 187
2022
Q2 		– Sell
-2,556
Closed -$203K – 255
2022
Q1 		$203K Buy
+2,556
New +$230K 0.06% 224

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

SkyOak Wealth's USNA Position: Q1 2023 in Review

SkyOak Wealth sold out of Usana Health Sciences (USNA) in Q1 2023, closing a stake of 4,268 shares — an estimated $227K sold.

SkyOak Wealth first reported a position in USNA in Q1 2022 and held it in 2 quarters. The position peaked at $227K in Q4 2022. 176 funds tracked by Wall St. Rank hold USNA as of Q1 2023.

  • SkyOak Wealth reported no remaining Usana Health Sciences position as of Q1 2023 after selling out during the quarter.
  • SkyOak Wealth sold 4,268 Usana Health Sciences shares in Q1 2023, an estimated $227K.
  • SkyOak Wealth first reported a position in Usana Health Sciences in Q1 2022 and held it in 2 quarters.
  • SkyOak Wealth's Usana Health Sciences position peaked at $227K in Q4 2022.
  • 176 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2023.

Based on SkyOak Wealth's 13F filing for Q1 2023, filed 2 May 2023.